Protection against chronic wound infection in type 2 diabetic patients
Diabetes millitus is considered one of the largest emerging threats to health in the 21st century. It has been associated with an impaired innate immune response such as lower respiratory burst function and, consequently, an increase in susceptibility to infection.
Type 2 Diabetes (T2D) patients are known to suffer from comprimised respiratory burst function. It makes them vulnerable to infection-related complications such as chronic wounds that represent a major public health problem in diabetics commonly leading to limb amputation.
FPP® corrects deficit in neutrophil respiratory burst capacity of T2D patients and consequently strengthens the ability of the body to fight infections. It also increases angiogenesis locally, thus promoting the healing process.
FPP® may influence multiple aspects of wound healing: wound infection management, local perfusion (wound cleansing via inflammatory response) up to angiogenesis.
Although it is composed mainly of carbohydrates, FPP® has no impact on patients’ fasting blood glucose, glucose levels, or lipid profile. It can therefore be safely used by people with diabetes.
How to use Immun'Âge for protection against wound infection in T2D patients
Action: Helps enhance the immune response.
Result: Helps protect against a weak immune response.
Dosage: 1 to 2 packet(s) per day for 2 to 3 months, 3 to 4 times a year
In case of wound injury
Action: Helps protect against wound infections.
Result: Helps improve wound healing.
Dosage: 3 packets per day until wound healing.
> Does oral supplementation of a fermented papaya preparation correct respiratory burst function of innate immune cells in type 2 diabetes mellitus patients?
R. Dickerson & Co | PMID:25268638
> May Dietary Supplementation Augment Respiratory Burst in Wound-Site Inflammatory Cells? A. DAS & Co | PMID:28810801